These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 1792903

  • 1. Efficacy of once weekly erythropoietin therapy in children on continuous ambulatory peritoneal dialysis.
    Hisano S, Kaku Y, Ueda K, Onoyama K.
    Acta Paediatr Jpn; 1991 Aug; 33(4):450-4. PubMed ID: 1792903
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Once weekly versus twice weekly subcutaneous administration of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis.
    Lui SF, Law CB, Ting SM, Li P, Lai KN.
    Clin Nephrol; 1991 Nov; 36(5):246-51. PubMed ID: 1752075
    [Abstract] [Full Text] [Related]

  • 4. Effect of erythropoietin in continuous ambulatory peritoneal dialysis patients: comparison between intravenous and intraperitoneal administration.
    Nasu T, Mitui H, Shinohara Y, Hayashida S, Ohtuka H.
    Perit Dial Int; 1992 Nov; 12(4):373-7. PubMed ID: 1420496
    [Abstract] [Full Text] [Related]

  • 5. Recombinant human erythropoietin dosage in children undergoing hemodialysis and continuous ambulatory peritoneal dialysis.
    Sieniawska M, Roszkowska-Blaim M.
    Pediatr Nephrol; 1997 Oct; 11(5):628-30. PubMed ID: 9323294
    [Abstract] [Full Text] [Related]

  • 6. Human erythropoietin in children undergoing continuous ambulatory peritoneal dialysis.
    Hisano S, Kaku Y, Ueda K, Onoyama K.
    Acta Paediatr Jpn; 1992 Feb; 34(1):36-41. PubMed ID: 1580151
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Once weekly subcutaneous administration of recombinant erythropoietin in children treated with CAPD.
    Goldraich I, Goldraich N.
    Adv Perit Dial; 1992 Feb; 8():440-3. PubMed ID: 1361843
    [Abstract] [Full Text] [Related]

  • 9. Subcutaneous recombinant human erythropoietin in hemodialysis and continuous ambulatory peritoneal dialysis.
    Pais MJ, Gaspar A, Santana A, Bruges M, Simões J.
    Perit Dial Int; 1993 Feb; 13 Suppl 2():S541-3. PubMed ID: 8399660
    [Abstract] [Full Text] [Related]

  • 10. Subcutaneous recombinant human erythropoietin in children with renal anemia on continuous ambulatory peritoneal dialysis.
    Aufricht C, Balzar E, Steger H, Lothaller MA, Frenzel K, Kohlhauser C, Kiss H, Khoss AE, Kernova T.
    Acta Paediatr; 1993 Nov; 82(11):959-62. PubMed ID: 8111178
    [Abstract] [Full Text] [Related]

  • 11. Subcutaneous recombinant human erythropoietin in patients on CAPD.
    Lye WC, Lee EJ.
    Adv Perit Dial; 1991 Nov; 7():285-7. PubMed ID: 1680447
    [Abstract] [Full Text] [Related]

  • 12. Anemia of chronic renal failure: treatment with erythropoietin.
    Navarro M, Alonso A, Avilla JM, Espinosa L.
    Child Nephrol Urol; 1991 Nov; 11(3):146-51. PubMed ID: 1777893
    [Abstract] [Full Text] [Related]

  • 13. Randomized prospective comparison between erythropoietin and androgens in CAPD patients.
    Navarro JF, Mora C, Macía M, García J.
    Kidney Int; 2002 Apr; 61(4):1537-44. PubMed ID: 11918762
    [Abstract] [Full Text] [Related]

  • 14. Effects of subcutaneous recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis.
    Di Paolo B, Marini A, Fiederling B, Di Liberato L, Santarelli P, Bucciarelli S, Stuard S, Paolantonio L, Albertazzi A.
    Perit Dial Int; 1993 Apr; 13 Suppl 2():S538-40. PubMed ID: 8399659
    [Abstract] [Full Text] [Related]

  • 15. Improved response to erythropoietin in peritoneal dialysis patients as compared to hemodialysis patients: role of iron deficiency.
    Raja R, Bloom E, Johnson R, Goldstein M.
    Adv Perit Dial; 1994 Apr; 10():135-8. PubMed ID: 7999811
    [Abstract] [Full Text] [Related]

  • 16. Correction of anemia in patients on continuous ambulatory peritoneal dialysis with subcutaneous recombinant erythropoietin twice a week: a long-term study.
    Cheng IK, Cy C, Chan MK, Yu L, Fang GX, Wei D.
    Clin Nephrol; 1991 May; 35(5):207-12. PubMed ID: 1855328
    [Abstract] [Full Text] [Related]

  • 17. Use of subcutaneous recombinant human erythropoietin in children undergoing continuous cycling peritoneal dialysis.
    Sinai-Trieman L, Salusky IB, Fine RN.
    J Pediatr; 1989 Apr; 114(4 Pt 1):550-4. PubMed ID: 2926567
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics and hematologic response to subcutaneous administration of recombinant human erythropoietin in children undergoing long-term peritoneal dialysis: a multicenter study.
    Montini G, Zacchello G, Perfumo F, Edefonti A, Bassi S, Cantaluppi A, Sarchi C, Cazzin M, Ferrari V, Boccazzi A.
    J Pediatr; 1993 Feb; 122(2):297-302. PubMed ID: 8429450
    [Abstract] [Full Text] [Related]

  • 19. Correction of anemia using self-administered daily subcutaneous erythropoietin in uremic patients on continuous ambulatory peritoneal dialysis.
    Li PK, Leung CB, Lui SF, Leung JC, Shek AC, Lai KN.
    Int J Artif Organs; 1993 Jul; 16(7):510-4. PubMed ID: 8370605
    [Abstract] [Full Text] [Related]

  • 20. Effect of subcutaneous and intraperitoneal administration of recombinant human erythropoietin on blood pressure and vasoactive hormones in patients on continuous ambulatory peritoneal dialysis.
    Lai KN, Lui SF, Leung JC, Law E, Nicholls MG.
    Nephron; 1991 Jul; 57(4):394-400. PubMed ID: 1828543
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.